| 发明名称 |
Treatment of myocardial infarction using tgf - beta antagonists |
| 摘要 |
<p>Disclosed is a use of an antagonist of TGF-β(TGF-Beta) in the manufacture of a medicament for reducing an adverse consequence of a myocardial infarction in a patient during an acute stage of the myocardial infarction, wherein the TGF-βantagonist is an antibody or antibody fragment that specifically binds to one or more isoforms of TGF-β.</p> |
| 申请公布号 |
NZ608813(A) |
申请公布日期 |
2014.11.28 |
| 申请号 |
NZ20110608813 |
申请日期 |
2011.09.01 |
| 申请人 |
GENZYME CORPORATION |
发明人 |
AKITA GEOFFREY Y.;LONNING SCOTT;GREGORY RICHARD C. JR.;KUDEJ AMELIA B. |
| 分类号 |
C07K16/22;A61K39/395;A61P9/10;C07K16/28 |
主分类号 |
C07K16/22 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
